In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 17, 2005, Pages 3930-3933

  Ottanà, Rosaria ^a   Carotti, Stefania ^b   Maccari, Rosanna ^a   Landini, Ida ^b   Chiricosta, Giuseppa ^a   Caciagli, Barbara ^b   Vigorita, Maria Gabriella ^a   Mini, Enrico ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antiproliferative activity; Cyclooxygenase; Human colon cancer; Thiazolidinones

Indexed keywords

2 PHENYLIMINO 5 (3 METHOXYPHENYLMETHYLIDENE) 3 PROPYL 4 THIAZOLIDINEDIONE; 3,3' (1,2 ETHANEDIYL)BIS[2 (4 METHOXYPHENYL) 4 THIAZOLIDINONE]; 4 THIAZOLIDINONE DERIVATIVE; 5 (3 TRIFLUOROMETHYLBENZYLIDENE) 2,4 THIAZOLIDINEDIONE; [5 (3 TRIFLUOROMETHYLBENZYLIDENE) 2,4 DIOXOTHIAZOLIDIN 3 YL]ACETIC ACID METHYL ESTER; ANTIMITOTIC AGENT; BISTHIAZOLIDINONE; CELECOXIB; CYCLOOXYGENASE 2; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINEDIONES;

EID: 23244463167     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.05.093     Document Type: Article

References (32)

1. W.L. Smith, and D.L. Dewitt Adv. Immunol. 62 1996 167
2. C.D. Funk, L.B. Funk, M.E. Kennedy, A.S. Pong, and G.A. Fitzgerald FASEB J. 5 1991 2304
3. J.L. Masferrer, B.S. Zweifeld, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakon, and K. Seibert Proc. Natl. Acad. Sci. U.S.A. 91 1994 3224
4. K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, and W. Perkins Proc. Natl. Acad. Sci. U.S.A. 91 1994 3224
5. H.R. Herschman Biochim. Biophys. Acta 1299 1996 125
6. P.C. Konturek, P. Brzozowski, S. Kwiecien, R. Pajdo, E.G. Hahn, and S.J. Konturek Aliment. Pharmacol. Ther. 12 1998 767
7. S.L. Kargman, G.P. O'Neill, P.J. Vickers, J.F. Evans, J.A. Mancini, and S. Jothy Cancer Res. 55 1995 2556
8. J. Shao, H. Sheng, H. Inoue, J.D. Morrow, and R.N. DuBois J. Biol. Chem. 275 2000 33951
9. Y. Eli, F. Przedecki, G. Levin, N. Kariv, and A. Raz Biochem. Pharmacol. 61 2001 565
10. H. Zhang, and X.F. Sun Am. J. Gastroenterol. 97 2002 1037
11. M.G. Vigorita, T. Previtera, R. Ottanà, I. Grillone, F. Monforte, M.T. Monforte, A. Trovato, and A. Rossitto Farmaco 52 1997 43
12. M.G. Vigorita, R. Ottanà, F. Monforte, R. Maccari, A. Trovato, M.T. Monforte, and M.F. Taviano Bioorg. Med. Chem. Lett. 1 2001 2791
13. R. Ottanà, E. Mazzon, L. Dugo, F. Monforte, R. Maccari, L. Sautebin, G. De Luca, M.G. Vigorita, S. Alcaro, F. Ortuso, A.P. Caputi, and S. Cuzzocrea Eur. J. Pharmacol. 448 2002 71
14. M.G. Vigorita, R. Ottanà, F. Monforte, R. Maccari, M.T. Monforte, A. Trovato, M.F. Taviano, N. Miceli, G. De Luca, S. Alcaro, and F. Ortuso Bioorg. Med. Chem. 11 2003 999
15. R.G. Kurumbail, A.M. Stevens, J.K. Gierse, J.J. McDonald, R.A. Stegeman, J.Y. Pak, D. Gildehaus, J.M. Miyashiro, T.D. Penning, K. Seibert, P.C. Isakson, and W.C. Stallings Nature 384 1996 644
16. R. Ottanà, R. Maccari, M.L. Barreca, G. Bruno, A. Rotondo, A. Rossi, I. Serraino, L. Sautebin, S. Cuzzocrea, and M.G. Vigorita Bioorg. Med. Chem. 13 2005 4243
17. G. Bruno, L. Costantino, C. Curinga, R. Maccari, F. Monforte, F. Nicolò, R. Ottanà, and M.G. Vigorita Bioorg. Med. Chem. 10 2002 1077
18. B. Zingarelli, G.J. Southan, E. Gilad, M. O'Connor, A.L. Salzman, and C. Szabo Br. J. Pharmacol. 120 1997 357
19. P. Patrignani, M.R. Panara, A. Greco, O. Fusco, C. Natoli, S. Iacobelli, F. Cipollone, A. Ganci, C. Creminon, J. Maclouf, and C. Patrono J. Pharmacol. Exp. Ther. 271 1994 1705
20. P. Patrignani Toxicol. Lett. 493 2000 112
21. C. Patrono, G. Ciabattoni, E. Pinca, F. Pugliese, G. Castrucci, A. De Salvo, M.A. Satta, and B.A. Peskar Thromb. Res. 17 1980 317
22. D.L. Dexter, J.A. Barbosa, and P. Calabresi Cancer Res. 39 1979 1020
23. M.G. Brattain, W.D. Fine, F.M. Khaled, J. Thompson, and D.E. Brattain Cancer Res. 41 1981 1751
24. J. Fogh, and G. Trempe J. Fogh Human Tumor Cells in Vitro 1975 Plenum Press New York 115 119
25. W.A. Tompkins, A.M. Watrach, J.D. Schmale, R.M. Schultz, and J.A. Harris J. Natl. Cancer Inst. 52 1974 1101
26. NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell Biochem. 1996, Suppl. 24.
27. L.C. His, S.J. Baek, and T.E. Eling Exp. Cell Res. 256 2000 563
28. I. Shureiqi, D. Chen, R. Lotan, P. Yang, R.A. Newman, S.M. Fischer, and S.M. Lippman Cancer Res. 60 2000 6846
29. H. Pyo, H. Choy, G.P. Amorino, J.S. Kim, Q. Cao, S.K. Hercules, and R.N. DuBois Clin. Cancer Res. 7 2001 2998
30. 50) by plotting cellular growth versus drug concentration on a semilogarithmic scale.
31. C. Waskewich, R.D. Blumenthal, H. Li, R. Stein, D.M. Goldenberg, and J. Burton Cancer Res. 62 2002 2029
32. H. Chen, Y. Fan, A. Natarajan, Y. Guo, J. Ijasere, F. Harbinski, L. Luus, W. Christ, H. Aktas, and J.A. Halperin Bioorg. Med. Chem. Lett. 14 2004 5401